inSEIT Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $429K

  • Investors
  • 5

inSEIT General Information

Description

Provider of enzyme immobilization services intended for industrial biocatalysis implementation. The company's platform combines artificial intelligence predictive models with experimental screening and data-driven optimization to enhance the stability and reusability of proteins, featuring methods that increase resistance to temperature and solvents while facilitating easier isolation through simple filtration, enabling clients in the pharmaceutical, food, and fragrance sectors to implement continuous production and cost-effective biocatalysis.

Contact Information

Website
www.inseit.ch
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Freiestrasse 3
  • 3012 Bern
  • Switzerland
+41 076
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Freiestrasse 3
  • 3012 Bern
  • Switzerland
+41 076

inSEIT Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

inSEIT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 23-Oct-2023 $429K Completed Generating Revenue
2. Seed Round 24-Aug-2022 Completed Generating Revenue
1. Grant 24-May-2022 $10.2K Completed Generating Revenue
To view inSEIT’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

inSEIT Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

inSEIT Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innosuisse Government Minority
Valuemaker Accelerator/Incubator Minority
Vaudoise Investment Solutions Corporation Minority
VentureLabs Accelerator/Incubator Minority
Venture Kick Accelerator/Incubator Minority
To view inSEIT’s complete investors history, request access »

inSEIT FAQs

  • When was inSEIT founded?

    inSEIT was founded in 2022.

  • Where is inSEIT headquartered?

    inSEIT is headquartered in Bern, Switzerland.

  • What is the size of inSEIT?

    inSEIT has 6 total employees.

  • What industry is inSEIT in?

    inSEIT’s primary industry is Biotechnology.

  • Is inSEIT a private or public company?

    inSEIT is a Private company.

  • What is inSEIT’s current revenue?

    The current revenue for inSEIT is .

  • How much funding has inSEIT raised over time?

    inSEIT has raised $471K.

  • Who are inSEIT’s investors?

    Innosuisse, Valuemaker, Vaudoise Investment Solutions, VentureLabs, and Venture Kick have invested in inSEIT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process